Latine individuals in the US face higher morbidity and mortality in skin cancer outcomes despite lower lifetime risk.

For diverse patient populations who are historically marginalized within health care, student-run clinics may offer a ...

Psychological resilience plays an important role in managing psoriasis symptoms and enhancing patient well-being, study ...

The increased urgency for vasectomy follow-through among men post-Dobbs aligns with previous administrative data indicating a ...

A recent review emphasizes the need for personalized treatment strategies and a multidisciplinary approach to effectively ...

Panelists discuss how several studies evaluating bispecific therapies in earlier lines of therapy for diffuse large B-cell lymphoma and follicular lymphoma suggest that patients with high-risk or ...

Sikander Ailawadhi, MD, discusses how the 2024 ASH Annual Meeting’s “Survivorship Burden and Patient Preferences Affecting Treatment Choices Among Multiple Myeloma Patients” study examined real-world ...

Panelists discuss how the sequencing of bispecific therapies in first-line vs later-line settings should be guided by factors such as disease stage, prior treatments, and patient-specific ...

Irina Dralyuk, MD, discusses how to best prevent vulnerable parties, especially children, from breathing in the toxic smoke in Los Angeles.

Panelists discuss how emerging data from ASH 2024 and recent NCCN guidelines supporting pirtobrutinib use in later-line CLL treatment are prompting oncologists to carefully evaluate factors like BTK ...

Panelist discusses how social determinants of health create significant diagnostic barriers for hidradenitis suppurativa through systemic inequities, limited health care access, and provider knowledge ...

Panelists discuss how they assess the individual support needs of patients diagnosed with diffuse large B-cell lymphoma or follicular lymphoma and describe an ideal model for industry-provided support ...